Abstract

Most preclinical studies using radiopharmaceuticals have been carried out on mice. In nuclear medicine and radioimmunotherapy procedures, I131 and Y90 have been widely used. For better estimation of doses from these procedures, S value plays a vital role. In this study, we have evaluated S values for major source and target combinations of Digimouse voxel phantom. We have used the Digimouse voxel phantom which was incorporated in Monte Carlo code FLUKA. Simulation studies were performed using Monte Carlo simulation code FLUKA. Latest publication of International Commission on Radiological Protection (ICRP) report 110 was used for assigning the values of organ compositions and densities. Photon and electron spectra for I131 and Y90 have been taken from the ICRP publication 107. For Digimouse voxel phantom, we have simulated 9 source regions with an assumed uniform distribution of I131 and Y90. S values have been evaluated for I131 and Y90 for different source and target combinations of Digimouse voxel phantom and presented in tabular form. The S values can be applied prospectively or retrospectively to the calculation of radiation doses internally exposed to I131 and Y90, including nuclear medicine and radioimmunotherapy procedures. These S values have been very important for the calculation of absorbed doses for various organs similar in size to present study for mice. In this study S value for I131 and Y90 were evaluated for major organs of digimouse voxel phantom. These S values are very important for absorbed dose calculation for various organs of a mouse.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.